Trademarkia Logo

Canada

C$
Trademark Search in Canada
ANNEXON BIOSCIENCES

View On IC.GC.CA

ANNEXON BIOSCIENCES
FORMALIZED

on 2 Jan 2025

Last Applicant/ Owned by

Annexon, Inc.

1400 Sierra Point Pkwy., Bldg. C, 2nd FlBrisbane CA 94005

US

Serial Number

2372469 filed on 22nd Nov 2024

ANNEXON BIOSCIENCES

Trademark usage description

pharmaceutical preparations for the treatment of immune system related diseases and disorders, complement-mediated diseases and disorders, neurologica Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of immune system related diseases and disorders, complement-mediated diseases and disorders, neurological diseases and disorders, and ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of Guillain-Barré syndrome, macular degeneration, geographic atrophy, Huntington's Disease, amyotrophic lateral sclerosis (ALS), lupus, cold agglutinin disease (CAD), chronic inflammatory demyelinating polyneuropathy (CIDP), and myasthenia gravis (MG).

Classification kind code

12

Class [042]
Pharmaceutical research and development; consulting services in the field of pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials.

Classification kind code

12

Class [044]
Providing medical information; providing medical information related to pharmaceuticals.

Classification kind code

12

Mark Details

Serial Number

2372469

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 257
on 2th Jan 2025		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 2th Jan 2025		Created
Submitted for opposition 31
on 2th Jan 2025		Formalized
Submitted for opposition 228
on 22nd Nov 2024		International Registration
Submitted for opposition 30
on 22nd Nov 2024		Filed